Agfa Healthcare has expanded its RIS portfolio with the purchase of a minority stake in Med2Rad, an Italian medical software company. Med2Rad developed the Elefante RIS, currently installed in more than 75 Italian hospitals. The Belgian company has for
Agfa Healthcare has expanded its RIS portfolio with the purchase of a minority stake in Med2Rad, an Italian medical software company. Med2Rad developed the Elefante RIS, currently installed in more than 75 Italian hospitals. The Belgian company has for several years been the exclusive marketer and vendor for Elefante in the Italian market, as part of an integrated RIS/PACS and as a stand-alone RIS. Agfa made the investment to allow greater integration between its Impax and Med2Rad's Elefante, leading eventually to a common IT platform, according to the firm.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.